Compare CRDO & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRDO | CNC |
|---|---|---|
| Founded | 2008 | 1984 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.4B | 20.0B |
| IPO Year | 2022 | 2001 |
| Metric | CRDO | CNC |
|---|---|---|
| Price | $121.50 | $42.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 17 |
| Target Price | ★ $183.18 | $41.25 |
| AVG Volume (30 Days) | 5.9M | ★ 6.1M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 261.11 | N/A |
| EPS | ★ 0.79 | N/A |
| Revenue | $436,775,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $197.64 | $8.24 |
| Revenue Next Year | $42.31 | $1.34 |
| P/E Ratio | $155.49 | ★ N/A |
| Revenue Growth | ★ 126.34 | 19.44 |
| 52 Week Low | $29.09 | $25.08 |
| 52 Week High | $213.80 | $66.03 |
| Indicator | CRDO | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 46.77 | 56.14 |
| Support Level | $94.22 | $37.25 |
| Resistance Level | $128.56 | $47.68 |
| Average True Range (ATR) | 9.66 | 1.55 |
| MACD | 1.55 | 0.37 |
| Stochastic Oscillator | 62.56 | 91.14 |
Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.